← Browse by Condition
Medical Condition

relapsed refractory large b cell lymphoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 2
NCT06489808 Phase 2
Recruiting

Linperlisib Combined With Immunochemotherapy in Relapsed/Refractory LBCL

Enrollment
89 pts
Location
China
Sponsor
Institute of Hematology & Bloo...
View Trial →